You are here

hypertension

Medtronic Finally Wins the Big One for Symplicity RDN Treatment

Medtronic Finally Wins the Big One for Symplicity RDN Treatment

Medical Devices and Diagnostics Industry

renal denervation

Flag link:

FDA Approves Renal Denervation for High Blood Pressure

FDA Approves Renal Denervation for High Blood Pressure

Medical Devices and Diagnostics Industry

Paradise ultrasound renal denervation system

renal denervation

Flag link:

Pharmacists treating hypertension patients could save US $1.1 trillion: Study

Pharmacists treating hypertension patients could save US $1.1 trillion: Study

Beckers Hospital Review

Flag link:

Amgen’s Krystexxa lowers blood pressure in chronic gout trial

Amgen’s Krystexxa lowers blood pressure in chronic gout trial

Clinical Trials Arena

Amgen Krystexxa

clinical trials

Flag link:

Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal

Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal

Fierce Biotech

KBP Biosciences

chronic kidney disease

Flag link:

J&J sends blood pressure drug back to Idorsia

J&J sends blood pressure drug back to Idorsia

BioPharma Dive

Flag link:

Hopes dim for Medtronic hypertension treatment after FDA panel rebuff

Hopes dim for Medtronic hypertension treatment after FDA panel rebuff

Medtech Dive

Symplicity Spyral

Flag link:

Evaluating renal denervation rivals, FDA advisory panel backs ReCor, shuns Medtronic

Evaluating renal denervation rivals, FDA advisory panel backs ReCor, shuns Medtronic

Fierce Biotech

renal denervation

Flag link:

Recor wins FDA panel’s backing for high blood pressure device

Recor wins FDA panel’s backing for high blood pressure device

Medtech Dive

renal denervation

Flag link:

Roche, Alnylam Ink Potential $2.8B RNAi Partnership for Hypertension

Roche, Alnylam Ink Potential $2.8B RNAi Partnership for Hypertension

BioSpace

Flag link:

Windtree's hypertension med snarled in Catch-22 as hunt for partners comes up dry

Windtree's hypertension med snarled in Catch-22 as hunt for partners comes up dry

Fierce Biotech

Windtree Therapeutics

Flag link:

Sky Labs publish findings on cuffless blood pressure measurement technology

Sky Labs publish findings on cuffless blood pressure measurement technology

Clinical Trials Arena

cuffless blood pressure measurement

Flag link:

Mineralys reports positive data from trial of lorundrostat for hypertension

Mineralys reports positive data from trial of lorundrostat for hypertension

Clinical Trials Arena

Mineralys Therapeutics

clinical trials

Flag link:

Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication

Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication

Endpoints

product recalls

Flag link:

IPO Doors Creak Open as Mineralys Seeks $192M

IPO Doors Creak Open as Mineralys Seeks $192M

BioSpace

Mineralys Therapeutics

Flag link:

Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension

Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension

Fierce Biotech

Flag link:

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Flag link:

CinCor shares dive after blood pressure drug fails key trial

CinCor shares dive after blood pressure drug fails key trial

BioPharma Dive

clinical trials

Flag link:

Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data

Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data

Endpoints

Flag link:

J&J, Idorsia plan filings for aprocitentan data in resistant hypertension

J&J, Idorsia plan filings for aprocitentan data in resistant hypertension

Pharmaphorum

resistant hypertension

Flag link:

Pages